XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (5,537,069) $ (1,066,947)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 499,887 364,765
Change in fair value of warrants (558,000) (6,698,692)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,127,361) (222,783)
Accounts payable (935,785) 2,813,995
Accrued expenses (440,836) (2,223,090)
Net cash used in operating activities (8,099,164) (7,032,752)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 19,783,423 3,875,000
Proceeds from exercise of warrants   540,000
Net cash provided by financing activities 19,783,423 4,415,000
Net increase (decrease) in cash and cash equivalents 11,684,259 (2,617,752)
Cash and cash equivalents, beginning of period 10,551,916 5,754,720
Cash and cash equivalents, end of period $ 22,236,175 $ 3,136,968